Clarus Therapeutics Holdings, Inc. ( CRXT) - Stock Earnings

CRXT Quarterly earnings

DateEarningsRevenue
2021Q4 -4.3 million USD 4.6 million USD
2022Q1 -14.9 million USD 4.0 million USD
2022Q2 -10.7 million USD 4.1 million USD

CRXT Yearly earnings

DateEarningsRevenue
2019 -41.7 million USD 0 USD
2020 4.3 million USD 6.4 million USD
2021 -40.6 million USD 14.0 million USD

CRXT

Price: $0.05

52 week price:
0.02
9.64

Earnings Per Share: -0.42 USD

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 2.7 million

Market Capitalization: 2.5 million

Links: